Results 81 to 90 of about 10,649 (222)
Pilot study investigating BP-180 in extracellular vesicles derived from blister fluid of bullous pemphigoid patients. [PDF]
Gasparini G +10 more
europepmc +1 more source
Recovery of Pure PVC From Pharmaceutical Composite Packaging via Dissolution‐Based Recycling
Closed‐loop pathway for pharmaceutical blister waste via selective dissolution‐based recycling (DBR) enables separation of PVDC and aluminum, PVC recovery and reprocessing into films with 30 phr recycled content, and validation for thermoforming applications.
Martin Schlummer +5 more
wiley +1 more source
Eosinophil Cationic Protein (ECP), a predictive marker of bullous pemphigoid severity and outcome
Bullous Pemphigoid (BP) is an inflammatory rare autoimmune bullous dermatosis, which outcome cannot be predicted through clinical investigations. Eosinophils are the main immune infiltrated cells in BP.
Delphine Giusti +6 more
doaj +1 more source
Cancer pain: current practice and emerging targets
Cancer pain (CP) arises from a complex interplay between the tumour and its microenvironment. Many patients experience a mixed pain phenotype that encompasses nociceptive, neuropathic and neuroinflammatory mechanisms, and vary across tumour type and disease stage. Despite decades of intensive research, the mainstay of cancer pain treatment is still non‐
Yi Ye +5 more
wiley +1 more source
Cyclophosphamide is associated with long‐term treatment‐free remission in patients with pemphigus
Summary Background and objective Pemphigus treatment has seen significant advancements, yet long‐term remission remains a challenge. Comparative data on the long‐term effectiveness of available therapies are limited. We compared 10‐year relapse rates in pemphigus patients treated with azathioprine or cyclophosphamide plus high‐dose IV corticosteroids ...
Bettina Santler +5 more
wiley +1 more source
Bullous Pemphigoid (BP) is a skin autoimmune blistering disease characterized by immune-mediated degradation of the dermo-epidermal junction and release of a large number of inflammatory cytokines. Interleukin-1β (IL-1β) is a pleiotropic pro-inflammatory
Sébastien Le Jan +6 more
doaj +1 more source
Irreversible ECM proteolysis by remodeling enzymes shapes development, homeostasis, and disease. ECM‐degrading proteases display cell specificity and are governed by shared mechanisms, exhibiting functional redundancy in generating matrikines, growth factors, and cytokines.
Inna Solomonov, Orit Kollet, Irit Sagi
wiley +1 more source
Blister fluid as a cellular input for <i>ex vivo</i> diagnostics in drug-induced severe cutaneous adverse reactions improves sensitivity and explores immunopathogenesis. [PDF]
Awad A +14 more
europepmc +1 more source
Consensus habitat‐suitability maps identify current hotspots of species richness across the Inner Western Anatolian mountain systems. Late‐century projections (2081–2100) under SSP2‐4.5 and SSP5‐8.5 show range shifts and changing richness patterns, intensifying at higher elevations.
Muhammed Arif Demir, Mahmut Kabalak
wiley +1 more source
Incidence of P200 pemphigoid: A nationwide study
The anti‐LAMB4 cell‐based immunoassay is a new serological technique that is far superior to dermal immunoblotting for detecting autoantibodies directed against the P200 protein. This method allows a re‐evaluation of the incidence of P200 pemphigoid, which appears to be considerably more frequent than epidermolysis bullosa acquisita.
Fabienne Jouen +7 more
wiley +1 more source

